These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 9784278)
1. Localization of metallothionein-I and -III expression in the CNS of transgenic mice with astrocyte-targeted expression of interleukin 6. Carrasco J; Hernandez J; Gonzalez B; Campbell IL; Hidalgo J Exp Neurol; 1998 Oct; 153(2):184-94. PubMed ID: 9784278 [TBL] [Abstract][Full Text] [Related]
2. Astrocyte-targeted expression of interleukin-3 and interferon-alpha causes region-specific changes in metallothionein expression in the brain. Giralt M; Carrasco J; Penkowa M; Morcillo MA; Santamaría J; Campbell IL; Hidalgo J Exp Neurol; 2001 Apr; 168(2):334-46. PubMed ID: 11259121 [TBL] [Abstract][Full Text] [Related]
3. Metallothioneins are upregulated in symptomatic mice with astrocyte-targeted expression of tumor necrosis factor-alpha. Carrasco J; Giralt M; Penkowa M; Stalder AK; Campbell IL; Hidalgo J Exp Neurol; 2000 May; 163(1):46-54. PubMed ID: 10785443 [TBL] [Abstract][Full Text] [Related]
4. Metallothionein-1+2 deficiency increases brain pathology in transgenic mice with astrocyte-targeted expression of interleukin 6. Giralt M; Penkowa M; Hernández J; Molinero A; Carrasco J; Lago N; Camats J; Campbell IL; Hidalgo J Neurobiol Dis; 2002 Apr; 9(3):319-38. PubMed ID: 11950277 [TBL] [Abstract][Full Text] [Related]
5. Transgenic expression of interleukin 6 in the central nervous system regulates brain metallothionein-I and -III expression in mice. Hernández J; Molinero A; Campbell IL; Hidalgo J Brain Res Mol Brain Res; 1997 Aug; 48(1):125-31. PubMed ID: 9379832 [TBL] [Abstract][Full Text] [Related]
6. Metallothionein-I overexpression alters brain inflammation and stimulates brain repair in transgenic mice with astrocyte-targeted interleukin-6 expression. Penkowa M; Camats J; Giralt M; Molinero A; Hernández J; Carrasco J; Campbell IL; Hidalgo J Glia; 2003 May; 42(3):287-306. PubMed ID: 12673834 [TBL] [Abstract][Full Text] [Related]
7. Metallothionein prevents neurodegeneration and central nervous system cell death after treatment with gliotoxin 6-aminonicotinamide. Penkowa M; Quintana A; Carrasco J; Giralt M; Molinero A; Hidalgo J J Neurosci Res; 2004 Jul; 77(1):35-53. PubMed ID: 15197737 [TBL] [Abstract][Full Text] [Related]
11. Astrocyte-targeted expression of interleukin-6 protects the central nervous system during neuroglial degeneration induced by 6-aminonicotinamide. Penkowa M; Camats J; Hadberg H; Quintana A; Rojas S; Giralt M; Molinero A; Campbell IL; Hidalgo J J Neurosci Res; 2003 Aug; 73(4):481-96. PubMed ID: 12898533 [TBL] [Abstract][Full Text] [Related]
12. Profound increase in sensitivity to glutamatergic- but not cholinergic agonist-induced seizures in transgenic mice with astrocyte production of IL-6. Samland H; Huitron-Resendiz S; Masliah E; Criado J; Henriksen SJ; Campbell IL J Neurosci Res; 2003 Jul; 73(2):176-87. PubMed ID: 12836160 [TBL] [Abstract][Full Text] [Related]
13. Astrocyte-specific overexpression of insulin-like growth factor-I promotes brain overgrowth and glial fibrillary acidic protein expression. Ye P; Popken GJ; Kemper A; McCarthy K; Popko B; D'Ercole AJ J Neurosci Res; 2004 Nov; 78(4):472-84. PubMed ID: 15468174 [TBL] [Abstract][Full Text] [Related]
14. Metallothionein-I overexpression decreases brain pathology in transgenic mice with astrocyte-targeted expression of interleukin-6. Molinero A; Penkowa M; Hernández J; Camats J; Giralt M; Lago N; Carrasco J; Campbell IL; Hidalgo J J Neuropathol Exp Neurol; 2003 Mar; 62(3):315-28. PubMed ID: 12638735 [TBL] [Abstract][Full Text] [Related]
15. IL-6 deficiency leads to reduced metallothionein-I+II expression and increased oxidative stress in the brain stem after 6-aminonicotinamide treatment. Penkowa M; Hidalgo J Exp Neurol; 2000 May; 163(1):72-84. PubMed ID: 10785446 [TBL] [Abstract][Full Text] [Related]
16. Induction of metallothionein mRNA and protein in murine astrocyte cultures. Kramer KK; Liu J; Choudhuri S; Klaassen CD Toxicol Appl Pharmacol; 1996 Jan; 136(1):94-100. PubMed ID: 8560486 [TBL] [Abstract][Full Text] [Related]
17. Altered central nervous system cytokine-growth factor expression profiles and angiogenesis in metallothionein-I+II deficient mice. Penkowa M; Carrasco J; Giralt M; Molinero A; Hernández J; Campbell IL; Hidalgo J J Cereb Blood Flow Metab; 2000 Aug; 20(8):1174-89. PubMed ID: 10950378 [TBL] [Abstract][Full Text] [Related]
18. Lipopolysaccharide-induced IL-12 expression in the central nervous system and cultured astrocytes and microglia. Stalder AK; Pagenstecher A; Yu NC; Kincaid C; Chiang CS; Hobbs MV; Bloom FE; Campbell IL J Immunol; 1997 Aug; 159(3):1344-51. PubMed ID: 9233631 [TBL] [Abstract][Full Text] [Related]
19. Neuroprotective effect of erythropoietin, and role of metallothionein-1 and -2, in permanent focal cerebral ischemia. Wakida K; Shimazawa M; Hozumi I; Satoh M; Nagase H; Inuzuka T; Hara H Neuroscience; 2007 Aug; 148(1):105-14. PubMed ID: 17624681 [TBL] [Abstract][Full Text] [Related]
20. GFAP promoter-controlled EGFP-expressing transgenic mice: a tool to visualize astrocytes and astrogliosis in living brain tissue. Nolte C; Matyash M; Pivneva T; Schipke CG; Ohlemeyer C; Hanisch UK; Kirchhoff F; Kettenmann H Glia; 2001 Jan; 33(1):72-86. PubMed ID: 11169793 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]